EMA Withdrawn: DepoCyte (cytarabine) — Pacira Limited

View source ↗

Summary

EMA has withdrawn DepoCyte (cytarabine) for meningeal neoplasms from Pacira Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningeal Neoplasms

Drugs mentioned

• Depocyte

Snippet

Status: Withdrawn. Therapeutic area: Meningeal Neoplasms. MAH: Pacira Limited. Decision date: 26/06/2017